A computational fluid dynamics method was used for prediction of flow behavior and band profiles of small- and macro-molecule compounds eluting in extra-column volumes (ECV) of an Äkta chromatographic system. The model compounds were: acetone, bovine serum albumin and an antibody. The construction of ECV was approximated by different types of geometries, starting from the simplest two-dimensional (2D) arrangement consisting of a straight capillary tube, and ending with a three-dimensional system (3D), which accounted for the flow path curvature of individual elements of ECV, including: injection loop capillary, multi-way valve, connecting capillary and detector cell. The accuracy of the model predictions depended on the flow path length and the eluent flowrate. 2D-geometry models reproduced pretty well the shapes of band profiles recorded at the lowest eluent flowrate used, but they failed for increased flowrates. The 3D-geometry model was found to be sufficiently accurate for all conditions investigated. It was exploited to analyze band broadening in the individual ECV elements. The simulation results revealed that the flow behavior in the injection loop capillaries strongly influenced the shape of band profiles, particularly at higher eluent velocities. This was attributed to the formation of Dean vertices triggered by centrifugal forces in curved parts of the eluent flow path.
Intensive training induces redox and inflammatory signaling that may facilitate adaptation but can also reflect excessive physiological strain. In this exploratory pilot longitudinal study, we assessed whether 8-iso-prostaglandin F2α (8-iso-PGF2α), a lipid peroxidation marker, and transcripts related to arachidonic acid lipoxygenase pathways change during a 10-week preparatory training period in elite female volleyball players. Twelve professional athletes were sampled at baseline after a training break and after training completion. 8-iso-PGF2α was quantified by gas chromatography–mass spectrometry (GC-MS), and the relative expression of arachidonate 5-lipoxygenase (ALOX5), arachidonate 12-lipoxygenase (ALOX12), and arachidonate 15-lipoxygenase (ALOX15) genes was measured by reverse transcription quantitative polymerase chain reaction (RT-qPCR) in leukocytes and plasma-derived RNA. Training increased 8-iso-PGF2α from 0.06 [0.05–0.09] to 0.16 [0.08–0.22] ng/mL (p = 0.03). ALOX5 expression increased in leukocytes (0.80 ± 0.29 vs. 1.00 ± 0.29; p = 0.02) and plasma-derived RNA (0.03 [0.02–0.06] vs. 0.06 [0.05–0.11]; p = 0.04), whereas no statistically detectable pre-to-post changes were observed for ALOX12 and ALOX15 expression. Given the exploratory design and small sample size, these results should be interpreted as hypothesis-generating. The observed changes suggest that 8-iso-PGF2α and ALOX5 are associated with physiological responses to preparatory training and exercise-induced lipid oxidative remodeling; however, their potential utility for monitoring training adaptation requires validation in larger, prospectively designed controlled cohorts.
Monoclonal antibodies represent one of the fastest-growing sectors of the biopharmaceutical industry. Their high therapeutic efficacy and reduced incidence of adverse effects compared to conventional therapies have led to an increasing demand for these products. The costliest stages of monoclonal antibody production are the separation and purification processes, which underscores the need for continuous development and optimization of applied methodologies. Active pharmaceutical ingredients must exhibit high purity and preserved biological activity in order to meet stringent regulatory requirements. Macromolecules such as monoclonal antibodies possess complex conformational structures that significantly influence their stability. The application of multi-step chromatographic processes during purification from cell culture harvests may induce structural alterations, including protein unfolding and aggregation, ultimately resulting in decreased product quality and therapeutic effectiveness. Such structural changes may also increase immunogenicity risk and reduce product shelf life, posing additional challenges for downstream processing. In addition, chromatographic media create microenvironments that differ markedly from bulk solution (e.g., high local protein concentration, confined pore spaces and heterogeneous surface chemistry). These effects can promote either self-association driven by colloidal interactions or partial unfolding followed by irreversible aggregation, depending on the unit operation and operating window. Practical mitigation is therefore rarely achieved by a single lever; instead, it requires an integrated view of resin selection, buffer composition (pH, salt type and ionic strength, and stabilizing additives), residence time and temperature, as well as an analytics strategy that combines orthogonal aggregation assays with structural probes. This work discusses the phenomena of unfolding and aggregation of therapeutic proteins, with particular emphasis on monoclonal antibodies occurring during chromatographic purification. Furthermore, key analytical methods, characterization techniques, and mitigation strategies aimed at improving product quality and reducing manufacturing costs are reviewed.